Chimerix (CMRX) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

Chimerix Revenue Highlights


Latest Revenue (Y)

$324.00K

Latest Revenue (Q)

$129.00K

Main Segment (Y)

Contract And Grant

Chimerix Revenue by Period


Chimerix Revenue by Year

DateRevenueChange
2023-12-31$324.00K-99.04%
2022-12-31$33.82M1609.15%
2021-12-31$1.98M-63.16%
2020-12-31$5.37M-57.09%
2019-12-31$12.52M73.49%
2018-12-31$7.22M60.57%
2017-12-31$4.49M-21.19%
2016-12-31$5.70M-47.02%
2015-12-31$10.76M166.39%
2014-12-31$4.04M-7.55%
2013-12-31$4.37M-87.04%
2012-12-31$33.72M178.65%
2011-12-31$12.10M605.60%
2010-12-31$1.72M-

Chimerix generated $324.00K in revenue during NA 2023, up -99.04% compared to the previous quarter, and up 4.49% compared to the same period a year ago.

Chimerix Revenue by Quarter

DateRevenueChange
2024-06-30$129.00K100.00%
2024-03-31--100.00%
2023-12-31$4.00K-63.64%
2023-09-30$11.00K-57.69%
2023-06-30$26.00K-90.81%
2023-03-31$283.00K-65.23%
2022-12-31$814.00K-97.50%
2022-09-30$32.55M7298.86%
2022-06-30$440.00K2833.33%
2022-03-31$15.00K-67.39%
2021-12-31$46.00K-57.01%
2021-09-30$107.00K-72.63%
2021-06-30$391.00K-72.75%
2021-03-31$1.44M28.13%
2020-12-31$1.12M-30.39%
2020-09-30$1.61M14.76%
2020-06-30$1.40M12.97%
2020-03-31$1.24M-81.66%
2019-12-31$6.77M245.61%
2019-09-30$1.96M36.16%
2019-06-30$1.44M-38.96%
2019-03-31$2.36M-51.56%
2018-12-31$4.86M1218.16%
2018-09-30$369.00K-69.07%
2018-06-30$1.19M51.01%
2018-03-31$790.00K-57.16%
2017-12-31$1.84M105.57%
2017-09-30$897.00K32.89%
2017-06-30$675.00K-37.38%
2017-03-31$1.08M-45.56%
2016-12-31$1.98M203.22%
2016-09-30$653.00K-64.53%
2016-06-30$1.84M49.92%
2016-03-31$1.23M-60.51%
2015-12-31$3.11M36.94%
2015-09-30$2.27M-45.18%
2015-06-30$4.14M234.65%
2015-03-31$1.24M7.09%
2014-12-31$1.16M-2.45%
2014-09-30$1.19M28.94%
2014-06-30$919.00K17.82%
2014-03-31$780.00K-11.26%
2013-12-31$879.00K-3.62%
2013-09-30$912.00K12.87%
2013-06-30$808.00K-54.38%
2013-03-31$1.77M-50.54%
2012-12-31$3.58M-82.83%
2012-09-30$20.86M236.12%
2012-06-30$6.21M101.59%
2012-03-31$3.08M-

Chimerix generated $129.00K in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up 45.58% compared to the same period a year ago.

Chimerix Revenue Breakdown


Chimerix Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Procurement-$31.97M---
Royalty-$375.00K---
Contract And Grant$275.00K----
License$49.00K$536.00K$51.00K$98.00K$4.92M
Contract And Grant Revenue-$942.00K$1.93M--
Contract---$5.27M$7.60M

Chimerix's latest annual revenue breakdown by segment (product or service), as of Dec 23: Contract And Grant (84.88%), and License (15.12%).

Quarterly Revenue by Product

Product/ServiceJun 24Dec 23Sep 23Jun 23Mar 23Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
Contract And Grant$129.00K$4.00K$11.00K$26.00K$234.00K$503.00K----------
License--$49.00K$81.00K$440.00K$15.00K$46.00K$2.00K$1.00K$2.00K$4.00K$18.00K$6.00K$70.00K--
Procurement---$31.97M------------
Contract and Grant--------$105.00K$390.00K$1.43M-----
Contract------------$1.12M$1.59M$1.40M$1.17M

Chimerix's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Contract And Grant (100.00%).

Chimerix Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$101.21M$25.11M
SPROSpero Therapeutics$96.73M$10.20M
MREOMereo BioPharma Group$10.00M-
ASMBAssembly Biosciences$7.16M$5.79M
CMRXChimerix$324.00K$129.00K
XFORX4 Pharmaceuticals-$563.00K
DAWNDay One Biopharmaceuticals-$20.07M
NXTCNextCure--
TILInstil Bio--
NLTXNeurogene--
TERNTerns Pharmaceuticals--
ACHLAchilles Therapeutics--

CMRX Revenue FAQ


Chimerix's yearly revenue for 2023 was $324K, representing a decrease of -99.04% compared to 2022. The company's yearly revenue for 2022 was $33.82M, representing an increase of 1609.15% compared to 2021. CMRX's yearly revenue for 2021 was $1.98M, representing a decrease of -63.16% compared to 2020.

Chimerix's quarterly revenue for Q2 2024 was $129K, a 100.00% increase from the previous quarter (Q1 2024), and a 396.15% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023). CMRX's quarterly revenue for Q4 2023 was $4K, a -63.64% decrease from the previous quarter (Q3 2023), and a -99.51% decrease year-over-year (Q4 2022).

Chimerix's revenue growth rate for the last 3 years (2021-2023) was -83.63%, and for the last 5 years (2019-2023) was -97.41%.

Chimerix's revenue streams in c 23 are Contract And Grant, and License. Contract And Grant generated $275K in revenue, accounting 84.88% of the company's total revenue License generated $49K in revenue, accounting 15.12% of the company's total revenue, down -90.86% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Chimerix was Contract And Grant. This segment made a revenue of $275K, representing 84.88% of the company's total revenue.